PRMT5 Interacting Partners and Substrates in Oligodendrocyte Lineage Cells

被引:8
|
作者
Dansu, David K. [1 ,2 ]
Liang, Jialiang [3 ,4 ]
Selcen, Ipek [1 ,2 ]
Zheng, Haiyan [5 ,6 ]
Moore, Dirk F. [7 ]
Casaccia, Patrizia [1 ,2 ]
机构
[1] CUNY, Adv Sci Res Ctr, Neurosci Initiat, New York, NY 10021 USA
[2] CUNY, Grad Ctr, Grad Program Biochem, New York, NY 10021 USA
[3] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY USA
[4] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY USA
[5] Ctr Adv Biotechnol & Med, Piscataway, NJ USA
[6] Rutgers Biomed & Hlth Sci, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ USA
[7] Rutgers State Univ, Sch Publ Hlth, Dept Biostat, Piscataway, NJ USA
关键词
brain; arginine methylation; RNA processing; epigenetics; iTRAQ; HISTONE DEACETYLASE ACTIVITY; METHYLTRANSFERASE; 7; PRMT7; 3 MAJOR FORMS; ARGININE METHYLATION; CEREBROSPINAL-FLUID; SM PROTEINS; RNA; IDENTIFICATION; EXPRESSION; COMPLEX;
D O I
10.3389/fncel.2022.820226
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The protein arginine methyl transferase PRMT5 is an enzyme expressed in oligodendrocyte lineage cells and responsible for the symmetric methylation of arginine residues on histone tails. Previous work from our laboratory identified PRMT5 as critical for myelination, due to its transcriptional regulation of genes involved in survival and early stages of differentiation. However, besides its nuclear localization, PRMT5 is found at high levels in the cytoplasm of several cell types, including oligodendrocyte progenitor cells (OPCs) and yet, its interacting partners in this lineage, remain elusive. By using mass spectrometry on protein eluates from extracts generated from primary oligodendrocyte lineage cells and immunoprecipitated with PRMT5 antibodies, we identified 1196 proteins as PRMT5 interacting partners. These proteins were related to molecular functions such as RNA binding, ribosomal structure, cadherin and actin binding, nucleotide and protein binding, and GTP and GTPase activity. We then investigated PRMT5 substrates using iTRAQ-based proteomics on cytosolic and nuclear protein extracts from CRISPR-PRMT5 knockdown immortalized oligodendrocyte progenitors compared to CRISPR-EGFP controls. This analysis identified a similar number of peptides in the two subcellular fractions and a total number of 57 proteins with statistically decreased symmetric methylation of arginine residues in the CRISPR-PRMT5 knockdown compared to control. Several PRMT5 substrates were in common with cancer cell lines and related to RNA processing, splicing and transcription. In addition, we detected ten oligodendrocyte lineage specific substrates, corresponding to proteins with high expression levels in neural tissue. They included: PRC2C, a proline-rich protein involved in methyl-RNA binding, HNRPD an RNA binding protein involved in regulation of RNA stability, nuclear proteins involved in transcription and other proteins related to migration and actin cytoskeleton. Together, these results highlight a cell-specific role of PRMT5 in OPC in regulating several other cellular processes, besides RNA splicing and metabolism.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells
    Maria Patrizia Mongiardi
    Mauro Savino
    Laura Bartoli
    Sara Beji
    Simona Nanni
    Fiorella Scagnoli
    Maria Laura Falchetti
    Annarita Favia
    Antonella Farsetti
    Andrea Levi
    Sergio Nasi
    Barbara Illi
    Scientific Reports, 5
  • [42] The role of PRMT5 in MYC-driven medulloblastoma
    Chaturvedi, Nagendra K.
    Kesherwani, Varun
    Kling, Matthew J.
    Ray, Sutapa
    McGuire, Timothy R.
    Joshi, Shantaram S.
    Sharp, J. Graham
    Coulter, Don W.
    CANCER RESEARCH, 2019, 79 (13)
  • [43] Molecular basis for substrate recruitment to the PRMT5 methylosome
    Mulvaney, Kathleen M.
    Blomquist, Christa
    Acharya, Nischal
    Li, Ruitong
    Ranaghan, Matthew J.
    O'Keefe, Meghan
    Rodriguez, Diego J.
    Young, Michael J.
    Kesar, Devishi
    Pal, Debjani
    Stokes, Matthew
    Nelson, Alissa J.
    Jain, Sidharth S.
    Yang, Annan
    Mullin-Bernstein, Zachary
    Columbus, Josie
    Bozal, Fazli K.
    Skepner, Adam
    Raymond, Donald
    LaRussa, Salvatore
    McKinney, David C.
    Freyzon, Yelena
    Baidi, Yossef
    Porter, Dale
    Aguirre, Andrew J.
    Ianari, Alessandra
    McMillan, Brian
    Sellers, William R.
    MOLECULAR CELL, 2021, 81 (17) : 3481 - +
  • [44] Flavokawain A is a natural inhibitor of PRMT5 in bladder cancer
    Liu, Shuangjie
    Liu, Zhuonan
    Piao, Chiyuan
    Zhang, Zhe
    Kong, Chuize
    Yin, Lei
    Liu, Xi
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [45] Role of pICLn in Methylation of Sm Proteins by PRMT5
    Pesiridis, G. Scott
    Diamond, Evan
    Van Duyne, Gregory D.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (32) : 21347 - 21359
  • [46] Prmt5 differentiates developmental vs regenerative myogenesis
    Zhang, Ting
    Braun, Thomas
    Zhou, Yonggang
    ONCOTARGET, 2015, 6 (34) : 35153 - 35154
  • [47] Flavokawain A is a natural inhibitor of PRMT5 in bladder cancer
    Shuangjie Liu
    Zhuonan Liu
    Chiyuan Piao
    Zhe Zhang
    Chuize Kong
    Lei Yin
    Xi Liu
    Journal of Experimental & Clinical Cancer Research, 41
  • [48] Prmt5: a guardian of the germline protects future generations
    Berrens, Rebecca V.
    Reik, Wolf
    EMBO JOURNAL, 2015, 34 (06): : 689 - 690
  • [49] PRMT5 INHIBITION SENSITIZES GLIOBLASTOMA NEUROSPHERES TO TEMOZOLOMIDE
    Rivas, Sarah
    Rivera-Caraballo, Kimberly
    Murphy, Sara
    Otani, Yoshihiro
    Shelbourn, Allison
    Ampie, Leo
    Maric, Dragan
    Walbridge, Stuart
    Shah, Ashish
    Yan, Yuanqing
    Yoo, Young
    Heiss, John
    Kaur, Balveen
    Banasavadi-Siddegowda, Yeshavanath
    NEURO-ONCOLOGY, 2022, 24 : 226 - 227
  • [50] PRMT5 modulates the metabolic response to fasting signals
    Tsai, Wen-Wei
    Niessen, Sherry
    Goebel, Naomi
    Yates, John R., III
    Guccione, Ernesto
    Montminy, Marc
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (22) : 8870 - 8875